Innoviva Inc (INVA)
19.11
-0.04
(-0.21%)
USD |
NASDAQ |
Nov 21, 15:11
Innoviva Price: 19.11 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 19.09 | 19.22 | 18.97 | 19.15 | 2.033M |
| Nov 19, 2024 | 18.81 | 19.31 | 18.79 | 19.09 | 595245.0 |
| Nov 18, 2024 | 18.91 | 19.19 | 18.86 | 18.95 | 553637.0 |
| Nov 15, 2024 | 19.28 | 19.29 | 18.77 | 18.90 | 627919.0 |
| Nov 14, 2024 | 20.01 | 20.22 | 18.40 | 19.24 | 1.295M |
| Nov 13, 2024 | 21.24 | 21.26 | 20.05 | 20.10 | 679148.0 |
| Nov 12, 2024 | 20.10 | 21.28 | 19.97 | 20.32 | 2.331M |
| Nov 11, 2024 | 20.25 | 20.32 | 20.06 | 20.12 | 518781.0 |
| Nov 08, 2024 | 20.12 | 20.32 | 19.95 | 20.18 | 695692.0 |
| Nov 07, 2024 | 19.89 | 20.28 | 19.72 | 20.00 | 803070.0 |
| Nov 06, 2024 | 19.95 | 20.29 | 19.92 | 19.92 | 733831.0 |
| Nov 05, 2024 | 19.31 | 19.57 | 19.21 | 19.43 | 335759.0 |
| Nov 04, 2024 | 19.17 | 19.48 | 19.08 | 19.36 | 429318.0 |
| Nov 01, 2024 | 19.66 | 19.78 | 19.00 | 19.26 | 459008.0 |
| Oct 31, 2024 | 19.58 | 19.72 | 19.50 | 19.56 | 335997.0 |
| Oct 30, 2024 | 19.70 | 19.87 | 19.65 | 19.71 | 327003.0 |
| Oct 29, 2024 | 19.79 | 19.93 | 19.76 | 19.89 | 245035.0 |
| Oct 28, 2024 | 19.78 | 20.14 | 19.74 | 19.93 | 274760.0 |
| Oct 25, 2024 | 19.80 | 20.01 | 19.72 | 19.77 | 219149.0 |
| Oct 24, 2024 | 19.79 | 19.95 | 19.72 | 19.80 | 298756.0 |
| Oct 23, 2024 | 19.89 | 19.98 | 19.76 | 19.82 | 211477.0 |
| Oct 22, 2024 | 19.78 | 19.98 | 19.70 | 19.97 | 325899.0 |
| Oct 21, 2024 | 20.02 | 20.02 | 19.78 | 19.85 | 367725.0 |
| Oct 18, 2024 | 20.16 | 20.16 | 19.89 | 20.03 | 215950.0 |
| Oct 17, 2024 | 20.22 | 20.37 | 20.14 | 20.17 | 226913.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
8.11
Minimum
Mar 18 2020
20.32
Maximum
Nov 12 2024
14.33
Average
13.69
Median
Dec 16 2019
Price Benchmarks
| NovaBay Pharmaceuticals Inc | 0.70 |
| Palatin Technologies Inc | 0.9146 |
| iBio Inc | 2.40 |
| Theriva Biologics Inc | 1.24 |
| Oragenics Inc | 0.27 |
Price Related Metrics
| PE Ratio | 27.70 |
| PS Ratio | 3.995 |
| PEG Ratio | 0.4875 |
| Price to Book Value | 1.789 |
| Price to Free Cash Flow | 8.684 |
| Earnings Yield | 3.61% |
| Market Cap | 1.196B |
| PEGY Ratio | 0.4875 |
| Operating PE Ratio | 8.740 |
| Normalized PE Ratio | 14.55 |